STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy.

MLA

Xu, Duo, et al. “STING-Targeted PET Tracer for Early Assessment of Tumor Immunogenicity in Colorectal Cancer after Chemotherapy.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 3, Feb. 2024, pp. 641–55. EBSCOhost, https://doi.org/10.1007/s00259-023-06485-w.

APA

Xu, D., Lu, X., Yang, F., Jiang, Z., Yang, S., Bi, L., Liu, J., Shan, H., & Li, D. (2024). STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy. European Journal of Nuclear Medicine & Molecular Imaging, 51(3), 641–655. https://doi.org/10.1007/s00259-023-06485-w

Chicago

Xu, Duo, Xin Lu, Fan Yang, Zebo Jiang, Shirui Yang, Lei Bi, Jiani Liu, Hong Shan, and Dan Li. 2024. “STING-Targeted PET Tracer for Early Assessment of Tumor Immunogenicity in Colorectal Cancer after Chemotherapy.” European Journal of Nuclear Medicine & Molecular Imaging 51 (3): 641–55. doi:10.1007/s00259-023-06485-w.